Article

Is It Time to Anticipate the Use of Parp Inhibitors in Prostate Cancer Patients?

2023-07-03

Abstract excerpt

The possibility of treating more patients for a longer time, has exploded the concept of anticipation in the systemic treatment of metastatic prostate cancer (mPC). The genetic analysis of Damage DNA Repair (DDR) mutations in pathogenetic variants (PV) and the development of poly (adenosine diphosphate-ribose) polymerase (PARP) inhibitors led to the first valid precision medicine option tailored for mPC. PARP inhi...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 13703cb5-3147-5391-b6e4-8181f5804693
DOI: 10.20944/preprints202307.0013.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Is It Time to Anticipate the Use of Parp Inhibitors in Prostate Cancer Patients?DOI 10.20944/preprints202307.0013.v1Read

PARP Inhibitors in the Treatment of Prostate Cancer: From Scientific Rationale to Clinical DevelopmentSemantic proximity Read

PARP inhibitors in advanced prostate cancer: when to use them?Semantic proximity Read

[Poly(ADP-ribose) polymerase (PARP-)inhibitors as genetically based precision therapy in metastatic castration-resistent prostate cancer (mCRPC)].Semantic proximity Read

PARP Inhibitors in Prostate Cancer.Semantic proximity Read

Prostate cancer and PARP inhibitors: progress and challengesSemantic proximity Read

First-line combination treatment with PARP and androgen receptor–signaling inhibitors in HRR-deficient mCRPC: Applying clinical study findings to clinical practice in the United StatesSemantic proximity Read

PARP Inhibitors in Prostate Cancer: Broad Use or Patient Selection?Semantic proximity Read

PARP inhibitors for prostate cancerSemantic proximity Read

Double trouble for prostate cancer: synergistic action of AR blockade and PARPi in non-HRR mutated patientsSemantic proximity Read

Use of PARP inhibitors in prostate cancer: from specific to broader application.Semantic proximity Read

PARP Inhibitors and Prostate Cancer: To Infinity and BeyondBRCASemantic proximity Read

Targeting PARP in Prostate Cancer: Novelty, Pitfalls, and Promise.Semantic proximity Read